Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) EBT: 2020-2025

Historic EBT for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to -$69.4 million.

  • P3 Health Partners' EBT rose 3476.12% to -$69.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$278.5 million, marking a year-over-year decrease of 1178.8%. This contributed to the annual value of -$306.0 million for FY2024, which is 6654.29% down from last year.
  • As of Q3 2025, P3 Health Partners' EBT stood at -$69.4 million, which was up 3476.12% from -$41.7 million recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' EBT registered a high of -$24.7 million during Q1 2021, and its lowest value of -$903.1 million during Q2 2022.
  • For the 5-year period, P3 Health Partners' EBT averaged around -$123.7 million, with its median value being -$52.2 million (2023).
  • As far as peak fluctuations go, P3 Health Partners' EBT plummeted by 296507.41% in 2022, and later skyrocketed by 9697.09% in 2023.
  • P3 Health Partners' EBT (Quarter) stood at -$60.2 million in 2021, then plummeted by 780.73% to -$530.5 million in 2022, then soared by 87.31% to -$67.3 million in 2023, then tumbled by 84.43% to -$124.2 million in 2024, then surged by 44.08% to -$69.4 million in 2025.
  • Its EBT stands at -$69.4 million for Q3 2025, versus -$41.7 million for Q2 2025 and -$43.2 million for Q1 2025.